809
Views
26
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

, , , , , , , , , , , , , , , , & show all
Pages 120-122 | Received 15 May 2009, Accepted 27 May 2009, Published online: 26 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katrina Sweeney & Gunnel Halldén. (2016) Oncolytic adenovirus-mediated therapy for prostate cancer. Oncolytic Virotherapy 5, pages 45-57.
Read now
Laure Aurelian. (2013) Oncolytic virotherapy: the questions and the promise. Oncolytic Virotherapy 2, pages 19-29.
Read now

Articles from other publishers (24)

Xiao-Tong Chen, Shu-Yang Dai, Yong Zhan, Ran Yang, De-Qian Chen, Yi Li, En-Qing Zhou & Rui Dong. (2022) Progress of oncolytic virotherapy for neuroblastoma. Frontiers in Pediatrics 10.
Crossref
Antonietta Rosella Farina, Lucia Annamaria Cappabianca, Veronica Zelli, Michela Sebastiano & Andrew Reay Mackay. (2021) Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting. World Journal of Stem Cells 13:7, pages 685-736.
Crossref
Tanja A. Grein, Daniel Loewe, Hauke Dieken, Denise Salzig, Tobias Weidner & Peter Czermak. (2018) High titer oncolytic measles virus production process by integration of dielectric spectroscopy as online monitoring system. Biotechnology and Bioengineering 115:5, pages 1186-1194.
Crossref
M D Kumar, A Dravid, A Kumar & D Sen. (2016) Gene therapy as a potential tool for treating neuroblastoma—a focused review. Cancer Gene Therapy 23:5, pages 115-124.
Crossref
Johanna K. Kaufmann & Dirk M. Nettelbeck. 2016. Adenoviral Vectors for Gene Therapy. Adenoviral Vectors for Gene Therapy 529 549 .
Ayako Takenouchi, Kengo Saito, Eriko Saito, Takeshi Saito, Tomoro Hishiki, Tadashi Matsunaga, Naohisa Isegawa, Hideo Yoshida, Naomi Ohnuma & Hiroshi Shirasawa. (2015) Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain. Pediatric Surgery International 31:12, pages 1151-1159.
Crossref
Anna Kanerva, Anniina Koski, Ilkka Liikanen, Minna Oksanen, Timo Joensuu, Otto Hemminki, Juni Palmgren, Kari Hemminki & Akseli Hemminki. (2015) Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors. Molecular Therapy 23:2, pages 321-329.
Crossref
O. Hemminki, R. Immonen, J. Närväinen, A. Kipar, J. Paasonen, K.T. Jokivarsi, H. Yli-Ollila, P. Soininen, K. Partanen, T. Joensuu, S. Parvianen, S.K. Pesonen, A. Koski, M. Vähä-Koskela, V. Cerullo, S. Pesonen, O.H. Gröhn & A. Hemminki. (2014) In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders. International Journal of Cancer 134:12, pages 2878-2890.
Crossref
Lauren A. Gillory, Michael L. Megison, Jerry E. Stewart, Elizabeth Mroczek-Musulman, Hugh C. Nabers, Alicia M. Waters, Virginia Kelly, Jennifer M. Coleman, James M. Markert, G. Yancey Gillespie, Gregory K. Friedman & Elizabeth A. Beierle. (2013) Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma. PLoS ONE 8:10, pages e77753.
Crossref
Manuel Ramírez & Javier García-Castro. 2013. Stem Cell Therapeutics for Cancer. Stem Cell Therapeutics for Cancer 103 110 .
Chuan JinDi YuMatko ČančerBerith NilssonJustyna LejaMagnus Essand. (2013) Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy. Human Gene Therapy 24:8, pages 766-775.
Crossref
Yuan Li, Baofu Zhang, Hongwei Zhang, Xiaoyu Zhu, Dongchuan Feng, Deyong Zhang, Baobiao Zhuo, Liantao Li & Junnian Zheng. (2013) Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth. Journal of Cancer Research and Clinical Oncology 139:6, pages 933-941.
Crossref
Shu-Cheng Zhang, Wei-Lin Wang, Wei-Song Cai, Kai-Lei Jiang & Zheng-Wei Yuan. (2012) Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma. BMC Cancer 12:1.
Crossref
Shu-Cheng Zhang, Wei-Song Cai, Yao Zhang, Kai-Lei Jiang, Ke-Ren Zhang & Wei-Lin Wang. (2012) Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human neuroblastoma through a CD46 and nectin 4-independent pathway. Cancer Letters 325:2, pages 227-237.
Crossref
Vincenzo Cerullo, Iulia Diaconu, Valentina Romano, Mari Hirvinen, Matteo Ugolini, Sophie Escutenaire, Sirkka-Liisa Holm, Anja Kipar, Anna Kanerva & Akseli Hemminki. (2012) An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance. Molecular Therapy 20:11, pages 2076-2086.
Crossref
Johanna K. Kaufmann & Dirk M. Nettelbeck. (2012) Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond. Trends in Molecular Medicine 18:7, pages 365-376.
Crossref
Lotta Kangasniemi, Suvi Parviainen, Tommi Pisto, Mika Koskinen, Mika Jokinen, Tuula Kiviluoto, Vincenzo Cerullo, Harry Jalonen, Anniina Koski, Anna Kangasniemi, Anna Kanerva, Sari Pesonen & Akseli Hemminki. (2011) Effects of capsid‐modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer. International Journal of Cancer 131:1, pages 253-263.
Crossref
Sari Pesonen, Iulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, Mari Raki, Lotta Kangasniemi, Petri Nokisalmi, Gianpietro Dotti, Kilian Guse, Leena Laasonen, Kaarina Partanen, Eerika Karli, Elina Haavisto, Minna Oksanen, Aila Karioja‐Kallio, Päivi Hannuksela, Sirkka‐Liisa Holm, Satu Kauppinen, Timo Joensuu, Anna Kanerva & Akseli Hemminki. (2011) Integrin targeted oncolytic adenoviruses Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors. International Journal of Cancer 130:8, pages 1937-1947.
Crossref
Gregory K. Friedman, Kevin A. Cassady, Elizabeth A. Beierle, James M. Markert & G. Yancey Gillespie. (2012) Targeting pediatric cancer stem cells with oncolytic virotherapy. Pediatric Research 71:2-4, pages 500-510.
Crossref
Henry Fechner & Jens Kurreck. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 1415 1442 .
Vincenzo Cerullo, Iulia Diaconu, Lotta Kangasniemi, Maria Rajecki, Sophie Escutenaire, Anniina Koski, Valentina Romano, Noora Rouvinen, Tamara Tuuminen, Leena Laasonen, Kaarina Partanen, Satu Kauppinen, Timo Joensuu, Minna Oksanen, Sirkka-Liisa Holm, Elina Haavisto, Aila Karioja-Kallio, Anna Kanerva, Sari Pesonen, Petteri T Arstila & Akseli Hemminki. (2011) Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus. Molecular Therapy 19:9, pages 1737-1746.
Crossref
Maria Rajecki, Mari Raki, Sophie Escutenaire, Sari Pesonen, Vincenzo Cerullo, Andreas Helminen, Päivi Hannuksela, Kaarina Partanen, Leena Laasonen, Timo Joensuu, Lotta Kangasniemi, Elina Haavisto, Anna Kanerva, Laura Ahtiainen & Akseli Hemminki. (2010) Safety of Glucocorticoids in Cancer Patients Treated with Oncolytic Adenoviruses. Molecular Pharmaceutics 8:1, pages 93-103.
Crossref
Suresh RadhakrishnanEnrique MirandaMaria EkbladAlan HolfordMaria Tome PizarroNicholas R. LemoineGunnel Halldén. (2010) Efficacy of Oncolytic Mutants Targeting pRb and p53 Pathways Is Synergistically Enhanced When Combined with Cytotoxic Drugs in Prostate Cancer Cells and Tumor Xenografts. Human Gene Therapy 21:10, pages 1311-1325.
Crossref
Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire, Merja Särkioja, Mari Raki, Vincenzo Cerullo, Leena Laasonen, Ramon Alemany, Juan Rojas, Manel Cascallo, Kilian Guse, Maria Rajecki, Lotta Kangasniemi, Elina Haavisto, Aila Karioja-Kallio, Päivi Hannuksela, Minna Oksanen, Anna Kanerva, Timo Joensuu, Laura Ahtiainen & Akseli Hemminki. (2010) Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors. Clinical Cancer Research 16:11, pages 3035-3043.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.